Form D · Biotechnology

GRI BIO OPERATIONS, INC.

La Jolla, CA · CIK 0001639824

Offering snapshot reported Apr 28, 2023 · SEC filing

Reported sold
$15.6M
Offering amount: $15.6M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 21, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2023Initial$15,583,333No comparison1SEC filing
Dec 22, 2022Initial$1,250,050No comparison1SEC filing
Nov 8, 2018Initial$5,710,792No comparison4SEC filing
Apr 17, 2015Initial$4,378,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$245K (estimated)
Finders' fees
$0
Form D file number
021-480297

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Ecoban Securities Corporation29112

Source: Form D, filed Apr 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Albert Agro Director, Executive
Vipin Kumar Chaturvedi Director, Executive
Sean G Edwards Executive
Oppel Greef Executive
W Marc Hertz Director, Executive
Walter Marc Hertz Director, Executive
Vipin Kumar Director
Abraham Van Wyck Director
Abraham Van Wyk Director
Raymond Watt Director
Gerald Yakatan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2223 Avenida De La Playa, Suite 208
La Jolla, CA, 92037